Sinovac Biotech Ltd (NASDAQ:SVA)

7.83
Delayed Data
As of 3:59pm ET
 -0.05 / -0.63%
Today’s Change
4.60
Today|||52-Week Range
8.75
-0.63%
Year-to-Date
No recent news for Sinovac Biotech Ltd.

Today’s Trading

Previous close7.88
Today’s open7.87
Day’s range7.66 - 7.92
Volume17,092
Average volume (3 months)76,410
Market cap$465.5M
Data as of 3:59pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)-168.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+7.44%
P/E ratio23.7
Price/Sales4.64
Price/Book4.02

Competitors

 Today’s
change
Today’s
% change
CRBPCorbus Pharmaceutica...+0.15+2.38%
DEPODepomed Inc-0.04-0.60%
GLYCGlycoMimetics Inc+0.25+1.50%
AVEOAveo Pharmaceuticals...-0.02-0.77%
Data as of 4:00pm ET, 04/26/2018

Financials

Last reporting dateApril 11, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$72.4M
Annual profit (last year)-$3.1M
Net profit margin-4.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Wei Dong Yin
Chief Financial Officer &
Vice President
Nan Wang
Corporate headquarters
Beijing, Beijing

Forecasts